ARCHIVES

ODAC Advises Approval Of Tamoxifen For Male Breast Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 18 No. 46 | November 27, 1992

Download PDF Visit The Full Archive

Related Articles

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

National Academy Of Sciences To form Cancer Policy Board At NCI’s Request

August 16, 1996

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program

July 23, 1999

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007